Hormone Therapy in Menopause: Who Should Avoid It?

CONTRAINDICATIONS TO HORMONE THERAPY

Hormone therapy (HT) remains the most effective treatment for moderate to severe hot flashes, night sweats, and vaginal symptoms of menopause. For many women, it can greatly improve quality of life. But hormone therapy is not right for everyone. Some women have health conditions or risk factors that make HT unsafe, and careful screening is essential before starting treatment.

Absolute Contraindications

Hormone therapy should never be used in women with the following conditions:

• History of breast cancer

• Coronary heart disease or heart attack

• Previous blood clots (venous thromboembolism) or stroke

• Active liver disease

These conditions significantly increase the risks of hormone therapy and outweigh any potential benefits.

Relative Contraindications

Hormone therapy may be considered in some cases, but only with extreme caution and close medical supervision if any of the following are present:

• Uncontrolled high blood pressure

• High baseline risk of cardiovascular disease

• Unexplained vaginal bleeding

• Endometrial cancer

• Severe hypertriglyceridemia (very high triglycerides)

In these situations, the risks often outweigh the benefits, and alternatives to hormone therapy may be a better choice.

Timing Matters

Guidelines recommend starting hormone therapy within 10 years of menopause or before age 60 when possible. Beginning treatment later is linked with higher risks of cardiovascular events and complications.

Special Considerations in Higher-Risk Populations

Some women are more likely to experience severe menopause symptoms, including Black and Hispanic women, women with obesity, smokers, and those with anxiety or depression. These same groups often carry higher baseline risks for heart disease, diabetes, and blood clots, which can complicate the decision to use hormone therapy.

• Obesity and smoking increase the chance of blood clots and stroke. In these cases, transdermal (skin patch) estrogen may be safer than pills, since it carries a lower risk of clots.

• Women with anxiety or depression require careful screening because mood disorders can complicate how menopause symptoms are experienced and managed.

• Black and Hispanic women and those with lower socioeconomic status often have higher rates of hypertension, diabetes, and obesity, making personalized care and risk assessment even more important.

Shared Decision-Making is Key

The American College of Obstetricians and Gynecologists, the North American Menopause Society, and other leading organizations recommend against hormone therapy in women with a high risk of heart disease, blood clots, or breast cancer. For women with multiple health conditions or limited access to care, the decision must be individualized, balancing risks, benefits, and personal preferences.

Bottom Line

Hormone therapy can be life-changing for many women, but it is not safe for everyone. Women with a history of breast cancer, heart disease, stroke, blood clots, or liver disease should avoid HT altogether. Others may need a personalized approach, especially those in higher-risk groups.

At Luminous Health & Wellness, I focus on evidence-based, individualized menopause care. Together, we carefully review your medical history, risks, and goals so that you can make the best decision for your long-term health and quality of life.